<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(23)</volume><submitter>Ojo O</submitter><pubmed_abstract>Nutritional interventions such as the use of prebiotics can promote eubiosis of gut microbiome and maintain glucose homeostasis in patients with type 2 diabetes (T2D). However, it would appear that results of the effects of prebiotics on the community of microbes in the gut are not consistent. To examine the effect of prebiotics and oral antidiabetic agents on gut microbiome in patients with T2D. The PRISMA Extension Statement for Systematic Reviews and Network Meta-analyses was used to conduct this review. Searches were carried out in EMBASE, EBSCO-host databases, Google Scholar and the reference lists of articles for studies that are relevant to the research question, from database inception to 15 August 2022. The search strategy was based on PICOS framework. Network Meta-analysis which </pubmed_abstract><journal>Nutrients</journal><pagination>5139</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9739188</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Effect of Prebiotics and Oral Anti-Diabetic Agents on Gut Microbiome in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.</pubmed_title><pmcid>PMC9739188</pmcid><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Ojo O</pubmed_authors><pubmed_authors>Brooke J</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Ojo OO</pubmed_authors><pubmed_authors>Dong Q</pubmed_authors><pubmed_authors>Thompson T</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Effect of Prebiotics and Oral Anti-Diabetic Agents on Gut Microbiome in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.</name><description>Nutritional interventions such as the use of prebiotics can promote eubiosis of gut microbiome and maintain glucose homeostasis in patients with type 2 diabetes (T2D). However, it would appear that results of the effects of prebiotics on the community of microbes in the gut are not consistent. To examine the effect of prebiotics and oral antidiabetic agents on gut microbiome in patients with T2D. The PRISMA Extension Statement for Systematic Reviews and Network Meta-analyses was used to conduct this review. Searches were carried out in EMBASE, EBSCO-host databases, Google Scholar and the reference lists of articles for studies that are relevant to the research question, from database inception to 15 August 2022. The search strategy was based on PICOS framework. Network Meta-analysis which </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-06-01T01:39:41.674Z</modification><creation>2024-11-14T06:55:15.902Z</creation></dates><accession>S-EPMC9739188</accession><cross_references><pubmed>36501168</pubmed><doi>10.3390/nu14235139</doi></cross_references></HashMap>